Adakveo (crizanlizumab) – No superiority of crizanlizumab over placebo
14/02/2023
Medicines for human use
Direct healthcare professional communication (DHPC)
Crizanlizumab, ADAKVEO, Phase III STUDY (CSEG101A2301) shows no superiority of crizanlizumab over placebo.